This epigenetic rewiring can shift the balance between oncogenic and tumor-suppressive transcriptional networks, sensitizing MTAP-deleted cells to further perturbation of PRMT5 or its upstream regulator MAT2A. The gene discussed is PRMT5; the disease is neoplasm.